| Lactose (India) Ltd | 153 Cr. | 122 | 247/84.3 | 34.9 | 46.7 | 0.00 % | 12.9 % | 9.69 % | 10.0 |
| MPS Pharmaa Ltd | 3.96 Cr. | 2.07 | 4.33/1.90 | | 0.57 | 0.00 % | 9.79 % | 59.0 % | 10.0 |
| Gujarat Themis Biosyn Ltd | 4,735 Cr. | 435 | 443/192 | 106 | 22.8 | 0.16 % | 27.3 % | 21.7 % | 1.00 |
| Gujarat Terce Laboratories Ltd | 34.2 Cr. | 46.2 | 94.9/37.2 | | 8.73 | 0.00 % | 41.4 % | 14.6 % | 10.0 |
| Gujarat Inject (Kerala) Ltd | 30.1 Cr. | 20.6 | 29.1/17.0 | 31.4 | 6.83 | 0.00 % | 13.5 % | 11.0 % | 10.0 |
| Godavari Drugs Ltd | 62.5 Cr. | 83.0 | 134/78.9 | 16.5 | 57.6 | 0.00 % | 10.1 % | 10.6 % | 10.0 |
| Glenmark Life Sciences Ltd | 53,105 Cr. | 1,882 | 2,286/1,275 | 39.8 | 314 | 0.13 % | 19.4 % | 15.8 % | 1.00 |
| Gennex Laboratories Ltd | 323 Cr. | 14.2 | 23.8/10.8 | 19.6 | 8.21 | 0.00 % | 13.0 % | 10.2 % | 1.00 |
| Ganga Pharmaceuticals Ltd | 7.06 Cr. | 14.6 | 19.2/9.25 | 88.2 | 14.7 | 0.00 % | 3.18 % | 1.13 % | 10.0 |
| Fredun Pharmaceuticals Ltd | 721 Cr. | 1,526 | 1,526/635 | 30.7 | 299 | 0.05 % | 18.9 % | 15.8 % | 10.0 |
| Fervent Synergies Ltd | 112 Cr. | 22.4 | 32.0/15.0 | 34.2 | 11.1 | 0.00 % | 7.47 % | 7.47 % | 10.0 |
| Fermenta Biotech Ltd | 793 Cr. | 270 | 449/219 | 7.59 | 123 | 0.93 % | 23.0 % | 24.9 % | 5.00 |
| Fabino Enterprises Ltd | 4.83 Cr. | 23.0 | 39.0/22.8 | 37.2 | 20.4 | 0.00 % | 7.16 % | 3.08 % | 10.0 |
| Evoq Remedies Ltd | 13.6 Cr. | 5.47 | 9.28/2.11 | 7.74 | 17.9 | 0.00 % | 0.35 % | 0.26 % | 10.0 |
| Everest Organics Ltd | 398 Cr. | 410 | 477/112 | 64.1 | 72.0 | 0.00 % | 1.76 % | 2.23 % | 10.0 |
| Entero Healthcare Solutions Ltd | 4,774 Cr. | 1,097 | 1,584/1,045 | 46.6 | 396 | 0.00 % | 8.71 % | 5.63 % | 10.0 |
| Murae Organisor Ltd | 67.5 Cr. | 0.33 | 1.24/0.33 | 4.44 | 1.02 | 0.00 % | 4.20 % | 5.69 % | 1.00 |
| Dipna Pharmachem Ltd | 50.2 Cr. | 20.9 | 26.3/6.40 | 51.8 | 16.0 | 0.00 % | 6.64 % | 2.55 % | 10.0 |
| Decipher Labs Ltd | 9.63 Cr. | 9.53 | 17.2/9.50 | | 22.6 | 0.00 % | 4.67 % | 1.16 % | 10.0 |
| Coral Laboratories Ltd | 182 Cr. | 510 | 896/443 | 9.86 | 563 | 0.29 % | 17.4 % | 13.1 % | 10.0 |
| Concord Drugs Ltd | 64.2 Cr. | 64.2 | 71.2/26.1 | 165 | 34.1 | 0.00 % | 4.73 % | 0.88 % | 10.0 |
| Concord Biotech Ltd | 15,977 Cr. | 1,527 | 2,452/1,345 | 44.7 | 173 | 0.70 % | 28.4 % | 21.4 % | 1.00 |
| Colinz Laboratories Ltd | 19.1 Cr. | 41.8 | 88.7/37.9 | 39.8 | 20.7 | 0.00 % | 6.72 % | 5.43 % | 10.0 |
| Cian Healthcare Ltd | 14.7 Cr. | 5.87 | 5.87/2.97 | | 15.8 | 0.00 % | 5.22 % | 0.43 % | 10.0 |
| Chemo Pharma Laboratories Ltd | 18.7 Cr. | 125 | 154/63.0 | | 87.6 | 0.00 % | 5.17 % | 3.47 % | 10.0 |
| Checkpoint Trends Ltd | 33.2 Cr. | 60.7 | 60.7/9.41 | 369 | 1.02 | 0.00 % | 16.5 % | 9.17 % | 10.0 |
| Chandra Bhagat Pharma Ltd | 31.0 Cr. | 41.1 | 80.0/0.00 | 43.7 | 39.7 | 0.00 % | 6.00 % | 2.41 % | 10.0 |
| Brawn Biotech Ltd | 6.15 Cr. | 20.5 | 26.0/15.5 | | 11.2 | 0.00 % | 42.5 % | 41.3 % | 10.0 |
| Blue Jet Healthcare Ltd | 11,648 Cr. | 672 | 1,028/464 | 32.5 | 65.3 | 0.18 % | 39.8 % | 30.2 % | 2.00 |
| Bharat Immunological & Biological Corporation Ltd | 89.4 Cr. | 20.7 | 35.9/19.0 | | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 |
| Beryl Drugs Ltd | 11.7 Cr. | 23.0 | 43.7/17.4 | 50.7 | 18.7 | 0.00 % | 10.2 % | 6.30 % | 10.0 |
| Mankind Pharma Ltd | 1,01,345 Cr. | 2,455 | 3,055/2,115 | 56.0 | 355 | 0.04 % | 15.0 % | 13.9 % | 1.00 |
| BDH Industries Ltd | 269 Cr. | 467 | 524/241 | 28.2 | 119 | 0.96 % | 17.8 % | 14.2 % | 10.0 |
| Bacil Pharma Ltd | 62.1 Cr. | 43.2 | 62.6/31.6 | 55.9 | 17.7 | 0.00 % | 0.97 % | 0.98 % | 10.0 |
| Aurobindo Pharma Ltd | 64,822 Cr. | 1,106 | 1,500/994 | 19.1 | 557 | 0.36 % | 14.2 % | 11.1 % | 1.00 |
| Auro Laboratories Ltd | 138 Cr. | 222 | 303/170 | 200 | 69.0 | 0.00 % | 3.85 % | 4.33 % | 10.0 |
| Anuh Pharma Ltd | 799 Cr. | 79.7 | 123/74.0 | 17.3 | 32.5 | 1.88 % | 17.2 % | 13.4 % | 5.00 |
| ANG Lifesciences India Ltd | 41.3 Cr. | 31.6 | 50.4/21.0 | | 51.2 | 0.00 % | 3.54 % | 13.8 % | 10.0 |
| Acutaas Chemicals Ltd | 12,718 Cr. | 1,553 | 1,589/727 | 67.3 | 160 | 0.10 % | 19.9 % | 16.0 % | 5.00 |
| Amerise Biosciences Ltd | 3.96 Cr. | 0.60 | 1.45/0.60 | 79.2 | 0.81 | 0.00 % | 0.19 % | 0.19 % | 1.00 |
| Ambalal Sarabhai Enterprises Ltd | 254 Cr. | 33.1 | 68.0/30.0 | 13.5 | 18.3 | 0.00 % | 9.12 % | 6.25 % | 10.0 |
| Adline Chem Lab Ltd | 9.48 Cr. | 16.2 | 25.5/9.40 | | 2.55 | 0.00 % | % | % | 10.0 |
| Achyut Healthcare Ltd | 140 Cr. | 5.93 | 6.57/2.82 | 325 | 1.33 | 0.00 % | 2.26 % | 1.77 % | 1.00 |
| Abbott India Ltd | 63,399 Cr. | 29,835 | 37,000/25,260 | 43.6 | 1,992 | 1.59 % | 46.2 % | 35.7 % | 10.0 |
| Aarti Pharmalabs Ltd | 7,762 Cr. | 856 | 972/550 | 29.1 | 220 | 0.58 % | 17.4 % | 14.5 % | 5.00 |
| Aarey Drugs & Pharmaceuticals Ltd | 251 Cr. | 88.6 | 88.6/31.3 | 60.4 | 48.8 | 0.00 % | 6.38 % | 2.96 % | 10.0 |
| Zota Health Care Ltd | 4,666 Cr. | 1,538 | 1,577/535 | | 78.1 | 0.07 % | 17.0 % | 36.0 % | 10.0 |
| Wockhardt Ltd | 22,042 Cr. | 1,356 | 1,870/1,006 | | 268 | 0.00 % | 3.75 % | 1.22 % | 5.00 |
| Wanbury Ltd | 764 Cr. | 232 | 330/154 | 17.8 | 18.1 | 0.00 % | 36.7 % | 76.5 % | 10.0 |
| Vivimed Labs Ltd | 41.0 Cr. | 4.95 | / | | 4.24 | 0.00 % | 8.10 % | % | 2.00 |
| Venus Remedies Ltd | 610 Cr. | 456 | 568/270 | 13.0 | 420 | 0.00 % | 11.1 % | 7.16 % | 10.0 |
| Unichem Laboratories Ltd | 3,304 Cr. | 469 | 950/456 | 26.4 | 348 | 0.00 % | 6.24 % | 5.59 % | 2.00 |
| TTK Healthcare Ltd | 1,598 Cr. | 1,131 | 1,663/991 | 23.7 | 754 | 0.88 % | 9.26 % | 6.89 % | 10.0 |
| Torrent Pharmaceuticals Ltd | 1,19,594 Cr. | 3,534 | 3,790/2,886 | 59.2 | 224 | 0.91 % | 27.0 % | 26.5 % | 5.00 |
| Themis Medicare Ltd | 1,159 Cr. | 126 | 317/98.0 | | 43.7 | 0.40 % | 10.4 % | 7.65 % | 1.00 |
| Syncom Formulations (India) Ltd | 1,545 Cr. | 16.4 | 24.0/14.1 | 27.1 | 3.62 | 0.00 % | 18.6 % | 15.5 % | 1.00 |
| Cohance Lifesciences Ltd | 34,368 Cr. | 898 | 1,360/856 | 97.7 | 66.6 | 0.00 % | 14.9 % | 12.7 % | 1.00 |
| Suven Life Sciences Ltd | 4,554 Cr. | 200 | 303/102 | | 5.04 | 0.00 % | 87.0 % | 87.2 % | 1.00 |
| Sun Pharmaceuticals Industries Ltd | 3,98,050 Cr. | 1,659 | 1,924/1,547 | 34.7 | 301 | 0.96 % | 20.2 % | 16.9 % | 1.00 |
| Solara Active Pharma Sciences Ltd | 2,642 Cr. | 592 | 886/441 | 108 | 304 | 0.00 % | 6.01 % | 0.05 % | 10.0 |
| SMS Pharmaceuticals Ltd | 2,589 Cr. | 292 | 342/175 | 36.8 | 75.9 | 0.14 % | 12.2 % | 11.0 % | 1.00 |
| SMS Lifesciences India Ltd | 343 Cr. | 1,134 | 1,680/956 | 19.8 | 650 | 0.13 % | 11.8 % | 10.8 % | 10.0 |
| Shilpa Medicare Ltd | 6,986 Cr. | 357 | 502/265 | 54.3 | 121 | 0.14 % | 7.82 % | 4.21 % | 1.00 |
| Sequent Scientific Ltd | 5,416 Cr. | 215 | 232/111 | 179 | 28.1 | 0.00 % | 8.47 % | 3.21 % | 2.00 |
| Sanofi India Ltd | 10,799 Cr. | 4,689 | 7,010/4,146 | 30.3 | 340 | 2.50 % | 49.2 % | 47.2 % | 10.0 |
| RPG Life Sciences Ltd | 3,814 Cr. | 2,306 | 2,914/1,772 | 36.8 | 321 | 0.87 % | 32.8 % | 25.5 % | 8.00 |
| Procter & Gamble Health Ltd | 10,432 Cr. | 6,284 | 6,739/4,863 | 34.7 | 323 | 1.99 % | 47.8 % | 36.4 % | 10.0 |
| Pharmaids Pharmaceuticals Ltd | 174 Cr. | 49.4 | 87.5/31.9 | | 16.8 | 0.00 % | 17.4 % | 16.3 % | 10.0 |
| Pfizer Ltd | 24,345 Cr. | 5,322 | 5,993/3,701 | 36.0 | 922 | 0.66 % | 21.6 % | 16.4 % | 10.0 |
| Par Drugs & Chemicals Ltd | 126 Cr. | 102 | 348/81.0 | 8.88 | 80.4 | 0.00 % | 18.4 % | 13.6 % | 10.0 |
| Panacea Biotec Ltd | 2,761 Cr. | 451 | 582/278 | | 136 | 0.00 % | 4.57 % | 4.92 % | 1.00 |
| Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 |
| Orchid Pharma Ltd | 3,695 Cr. | 729 | 1,998/604 | 43.4 | 250 | 0.00 % | 8.07 % | 8.21 % | 10.0 |
| Neuland Laboratories Ltd | 20,782 Cr. | 16,198 | 18,100/10,060 | 158 | 1,188 | 0.07 % | 18.7 % | 14.8 % | 10.0 |
| Nectar Lifescience Ltd | 308 Cr. | 13.8 | 44.9/13.0 | | 42.6 | 0.00 % | 5.36 % | 11.2 % | 1.00 |
| Natco Pharma Ltd | 14,720 Cr. | 822 | 1,505/660 | 8.67 | 425 | 0.73 % | 32.8 % | 28.0 % | 2.00 |
| Morepen Laboratories Ltd | 2,657 Cr. | 48.5 | 91.7/41.7 | 28.7 | 21.1 | 0.41 % | 15.1 % | 11.8 % | 2.00 |
| Marksans Pharma Ltd | 8,071 Cr. | 178 | 359/162 | 23.0 | 54.4 | 0.45 % | 20.0 % | 16.8 % | 1.00 |
| Mangalam Drugs and Organics Ltd | 111 Cr. | 70.4 | 130/65.5 | | 93.9 | 0.00 % | 8.03 % | 4.71 % | 10.0 |
| Lyka Labs Ltd | 337 Cr. | 94.5 | 177/90.2 | 45.0 | 29.0 | 0.00 % | 9.91 % | 9.31 % | 10.0 |
| Lupin Ltd | 89,123 Cr. | 1,951 | 2,403/1,774 | 24.1 | 377 | 0.62 % | 21.3 % | 20.6 % | 2.00 |
| Lincoln Pharmaceuticals Ltd | 1,052 Cr. | 525 | 980/499 | 12.2 | 335 | 0.34 % | 17.3 % | 12.8 % | 10.0 |
| Laurus Labs Ltd | 47,119 Cr. | 873 | 944/440 | 92.5 | 84.6 | 0.14 % | 9.47 % | 7.75 % | 2.00 |
| Kwality Pharmaceuticals Ltd | 879 Cr. | 847 | 1,235/596 | 20.2 | 256 | 0.00 % | 18.2 % | 16.2 % | 10.0 |
| Krebs Biochemicals & Industries Ltd | 151 Cr. | 70.2 | 129/63.6 | | 67.8 | 0.00 % | 30.1 % | % | 10.0 |
| Kopran Ltd | 807 Cr. | 167 | 329/154 | 23.1 | 107 | 1.79 % | 9.75 % | 7.64 % | 10.0 |
| Kilitch Drugs (India) Ltd | 651 Cr. | 372 | 500/265 | 23.2 | 116 | 0.00 % | 15.7 % | 12.6 % | 10.0 |
| Jubilant Pharmova Ltd | 17,141 Cr. | 1,076 | 1,310/802 | 35.3 | 393 | 0.46 % | 9.54 % | 9.55 % | 1.00 |
| J B Chemicals & Pharmaceuticals Ltd | 26,172 Cr. | 1,671 | 1,998/1,303 | 38.2 | 221 | 0.93 % | 25.8 % | 20.1 % | 1.00 |
| Jagsonpal Pharmaceuticals Ltd | 1,471 Cr. | 220 | 328/175 | 34.5 | 36.1 | 1.13 % | 23.0 % | 18.6 % | 2.00 |
| Ipca Laboratories Ltd | 32,687 Cr. | 1,288 | 1,758/1,168 | 36.5 | 274 | 0.31 % | 14.7 % | 12.8 % | 1.00 |
| IOL Chemicals & Pharmaceuticals Ltd | 2,878 Cr. | 98.0 | 127/57.5 | 27.3 | 57.5 | 0.82 % | 8.86 % | 6.13 % | 2.00 |
| Ind-Swift Ltd | 85.4 Cr. | 15.8 | 34.7/12.0 | 10.9 | 74.2 | 0.00 % | 11.9 % | % | 2.00 |
| Ind-Swift Laboratories Ltd | 769 Cr. | 105 | 134/67.2 | 34.8 | 194 | 0.00 % | 0.78 % | 0.18 % | 10.0 |
| Indoco Remedies Ltd | 2,695 Cr. | 292 | 355/190 | | 111 | 0.07 % | 0.49 % | 7.02 % | 2.00 |
| Hikal Ltd | 2,963 Cr. | 240 | 465/236 | 46.8 | 102 | 0.58 % | 9.85 % | 7.38 % | 2.00 |
| Hester Biosciences Ltd | 1,466 Cr. | 1,723 | 2,786/1,243 | 39.0 | 369 | 0.41 % | 9.71 % | 9.18 % | 10.0 |
| Gufic BioSciences Ltd | 3,563 Cr. | 355 | 504/285 | 58.3 | 60.0 | 0.03 % | 13.2 % | 12.3 % | 1.00 |
| Granules India Ltd | 13,835 Cr. | 570 | 628/412 | 29.0 | 153 | 0.26 % | 15.1 % | 13.9 % | 1.00 |
| Glenmark Pharmaceuticals Ltd | 52,614 Cr. | 1,864 | 2,286/1,275 | 39.5 | 314 | 0.13 % | 19.4 % | 15.8 % | 1.00 |
| Glaxosmithkline Pharmaceuticals Ltd | 46,141 Cr. | 2,724 | 3,516/1,921 | 48.7 | 115 | 1.54 % | 63.2 % | 46.9 % | 10.0 |
| Gland Pharma Ltd | 31,594 Cr. | 1,918 | 2,131/1,200 | 27.8 | 592 | 0.94 % | 15.8 % | 11.6 % | 1.00 |
| FDC Ltd | 7,094 Cr. | 436 | 559/359 | 26.4 | 140 | 1.15 % | 15.9 % | 11.8 % | 1.00 |
| ERIS Lifesciences Ltd | 21,617 Cr. | 1,587 | 1,910/1,097 | 55.8 | 210 | 0.46 % | 12.2 % | 12.9 % | 1.00 |
| Dr Reddys Laboratories Ltd | 1,03,509 Cr. | 1,240 | 1,406/1,020 | 18.2 | 402 | 0.65 % | 22.7 % | 18.0 % | 1.00 |
| Dishman Carbogen Amcis Ltd | 4,497 Cr. | 287 | 322/169 | 37.9 | 372 | 0.00 % | 2.42 % | 0.32 % | 2.00 |
| Cipla Ltd | 1,26,771 Cr. | 1,569 | 1,612/1,310 | 23.5 | 386 | 0.83 % | 22.7 % | 17.8 % | 2.00 |
| Caplin Point Laboratories Ltd | 15,319 Cr. | 2,015 | 2,641/1,551 | 27.1 | 347 | 0.30 % | 25.8 % | 22.7 % | 2.00 |
| Brooks Laboratories Ltd | 361 Cr. | 123 | 203/95.6 | 178 | 33.3 | 0.00 % | 9.93 % | 12.2 % | 10.0 |
| Bliss GVS Pharma Ltd | 1,611 Cr. | 153 | 191/105 | 15.1 | 99.7 | 0.33 % | 11.7 % | 8.36 % | 1.00 |
| Biofil Chemicals & Pharmaceuticals Ltd | 64.1 Cr. | 39.4 | 75.0/39.0 | 23.0 | 11.5 | 0.00 % | 4.12 % | 3.03 % | 10.0 |
| Biocon Ltd | 47,890 Cr. | 358 | 406/291 | 132 | 180 | 0.14 % | 6.25 % | 4.76 % | 5.00 |
| Beta Drugs Ltd | 1,764 Cr. | 1,748 | 2,215/1,430 | 38.5 | 195 | 0.00 % | 27.0 % | 25.9 % | 10.0 |
| Bal Pharma Ltd | 129 Cr. | 81.1 | 141/76.3 | 18.0 | 48.6 | 1.48 % | 10.1 % | 9.66 % | 10.0 |
| Bafna Pharmaceuticals Ltd | 347 Cr. | 147 | 179/67.8 | 34.5 | 35.8 | 0.00 % | 8.34 % | 7.69 % | 10.0 |
| Astrazeneca Pharma India Ltd | 22,752 Cr. | 9,101 | 10,691/6,220 | 108 | 308 | 0.35 % | 33.4 % | 23.6 % | 2.00 |
| Amrutanjan Health Care Ltd | 2,021 Cr. | 699 | 843/544 | 37.1 | 113 | 0.66 % | 22.4 % | 16.5 % | 1.00 |
| Alpa Laboratories Ltd | 187 Cr. | 88.9 | 137/85.0 | 7.10 | 86.4 | 0.00 % | 15.0 % | 11.5 % | 10.0 |
| Alkem Laboratories Ltd | 66,048 Cr. | 5,524 | 6,250/4,492 | 29.0 | 1,002 | 0.81 % | 20.4 % | 19.4 % | 2.00 |
| Alembic Pharmaceuticals Ltd | 18,347 Cr. | 933 | 1,188/725 | 30.9 | 264 | 1.18 % | 13.0 % | 11.4 % | 2.00 |
| Albert David Ltd | 453 Cr. | 794 | 1,540/763 | 72.1 | 688 | 0.63 % | 6.45 % | 4.39 % | 10.0 |
| Ajanta Pharma Ltd | 30,712 Cr. | 2,458 | 3,235/2,022 | 33.0 | 303 | 1.14 % | 32.4 % | 24.9 % | 2.00 |
| Advanced Enzyme Technologies Ltd | 3,467 Cr. | 310 | 509/258 | 25.3 | 127 | 1.68 % | 13.1 % | 9.54 % | 2.00 |
| Aarti Drugs Limited | 4,823 Cr. | 525 | 575/312 | 26.9 | 136 | 0.19 % | 13.5 % | 13.0 % | 10.0 |
| Industry Average | 19,728.56 Cr | 1,182.89 | | 50.69 | 193.63 | 0.34% | 16.24% | 14.95% | 6.10 |
